Literature DB >> 2911847

The need for a loading dose of gentamicin in neonates.

K L Watterberg1, H W Kelly, P Angelus, C Backstrom.   

Abstract

We studied pharmacokinetic variables in 100 neonates to evaluate the need for a loading dose of gentamicin. The mean volume of distribution for gentamicin in this population was .542 +/- .205 L/kg. Forty-five percent of these patients would not achieve peak serum concentrations of greater than or equal to 5 micrograms/ml after one dose of 2.5 mg/kg. A loading dose of 4 mg/kg would result in a level of greater than or equal to 5 micrograms/ml in 92% of the patients. After this study, a 4 mg/kg loading dose was initiated at our institution. Peak and trough concentrations at steady state were compared in 50 patients receiving a loading dose and 40 patients who had not received a loading dose. No significant differences were found in peak or trough concentrations after three or more doses, verifying that a loading dose does not affect steady-state concentrations. Because gentamicin toxicities are related to accumulation over time, whereas therapeutic efficacy may be related to early attainment of therapeutic peak serum concentrations, we recommend a loading dose of 4 mg/kg in all neonates beginning gentamicin therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911847     DOI: 10.1097/00007691-198901000-00004

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

1.  The effect of sepsis upon gentamicin pharmacokinetics in neonates.

Authors:  M Lingvall; D Reith; R Broadbent
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

2.  Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors:  J T Gilman; P Gal
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

Review 3.  Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.

Authors:  Imke H Bartelink; Carin M A Rademaker; Alfred F A M Schobben; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Assessment of bioelectrical impedance for individualizing gentamicin therapy in neonates.

Authors:  J S Sidhu; B G Charles; E J Triggs; D I Tudehope; P H Gray; P A Steer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Time course of trough serum gentamicin concentrations in preterm and term neonates.

Authors:  M A de Cos; J Gómez-Ullate; F Gómez; J A Armijo
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of aminoglycosides in the neonate: a review.

Authors:  Gian Maria Pacifici
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

Review 7.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.